Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients

Radiation Oncology

Table 1 Patient and tum or characteristics of SBRT

Liver metastasis	N	%	HCC		N	%
	51	100			79	100
Primary cancer			Stage
Colon cancer	21	41.2		I	29	36.7
Rectal cancer	9	17.6		II	21	26.6
Lung cancer	5	9.8		III	5	6.3
Gastric cancer	5	9.8		IV	2	2.5
Cervical cancer	3	5.9		Recurrence	11	13.9
Breast cancer	3	5.9		NE	11	13.9
Pancreatic cancer	3	5.9
Bile duct cancer	1	2.0
Skin cancer	1	2.0
Number of SRT				Chilid-Pugh before SBRT
Single SRT	41	80.4		A	67	84.8
Two places	8	15.7		B	9	11.4
Tree	1	2.0		C	1	1.3
Four	1	2.0		NE	2	2.5
Sex
Female	17	33.3			19	24
Male	34	66.7			60	75.9
Tumor diameter (mm)
Range	13-54				6-70
Median	26				27
Performance status (ECOG)
0	32	62.7			34	43.0
1	13	25.5			39	49.4
2	5	9.8			4	5.1
3	1	2.0			1	1.3
Age (years old)
Range	33-90				38-95
Median	73				73
SRT total dose (Gy)
Range	30-60				40-60
Median	50				48
BED-10 (Gy)
Range	56-134.4				75-106
Median	105.6				96.3

ISSN: 1748-717X